Mechanical  ||| S:0 E:11 ||| JJ
thrombectomy  ||| S:11 E:24 ||| NN
for  ||| S:24 E:28 ||| IN
acute  ||| S:28 E:34 ||| JJ
ischemic  ||| S:34 E:43 ||| JJ
stroke  ||| S:43 E:50 ||| NN
using  ||| S:50 E:56 ||| VBG
the  ||| S:56 E:60 ||| DT
MERCI  ||| S:60 E:66 ||| NNP
retriever  ||| S:66 E:76 ||| NN
and  ||| S:76 E:80 ||| CC
penumbra  ||| S:80 E:89 ||| JJ
aspiration  ||| S:89 E:100 ||| JJ
systems  ||| S:100 E:108 ||| NNS
Intracranial  ||| S:108 E:121 ||| JJ
large-vessel  ||| S:121 E:134 ||| JJ
ischemia  ||| S:134 E:143 ||| NN
is  ||| S:143 E:146 ||| VBZ
associated  ||| S:146 E:157 ||| VBN
with  ||| S:157 E:162 ||| IN
poor  ||| S:162 E:167 ||| JJ
clinical  ||| S:167 E:176 ||| JJ
outcome  ||| S:176 E:184 ||| NN
and  ||| S:184 E:188 ||| CC
increased  ||| S:188 E:198 ||| JJ
mortality ||| S:198 E:207 ||| NN
.  ||| S:207 E:209 ||| .
Early  ||| S:209 E:215 ||| JJ
reperfusion  ||| S:215 E:227 ||| NN
of  ||| S:227 E:230 ||| IN
ischemic  ||| S:230 E:239 ||| JJ
tissue  ||| S:239 E:246 ||| NN
remains  ||| S:246 E:254 ||| VBZ
the  ||| S:254 E:258 ||| DT
goal  ||| S:258 E:263 ||| NN
of  ||| S:263 E:266 ||| IN
treatment  ||| S:266 E:276 ||| NN
of  ||| S:276 E:279 ||| IN
stroke ||| S:279 E:285 ||| NN
.  ||| S:285 E:287 ||| .
Intravenous  ||| S:287 E:299 ||| FW
tissue  ||| S:299 E:306 ||| FW
plasminogen  ||| S:306 E:318 ||| FW
activator  ||| S:318 E:328 ||| FW
( ||| S:328 E:329 ||| -LRB-
IV  ||| S:329 E:332 ||| NNP
tPA ||| S:332 E:335 ||| NNP
)  ||| S:335 E:337 ||| -RRB-
has  ||| S:337 E:341 ||| VBZ
been  ||| S:341 E:346 ||| VBN
shown  ||| S:346 E:352 ||| VBN
to  ||| S:352 E:355 ||| TO
improve  ||| S:355 E:363 ||| VB
clinical  ||| S:363 E:372 ||| JJ
outcomes  ||| S:372 E:381 ||| NNS
for  ||| S:381 E:385 ||| IN
patients  ||| S:385 E:394 ||| NNS
who  ||| S:394 E:398 ||| WP
experience  ||| S:398 E:409 ||| VBP
ischemic  ||| S:409 E:418 ||| JJ
stroke ||| S:418 E:424 ||| NN
,  ||| S:424 E:426 ||| ,
but  ||| S:426 E:430 ||| CC
it  ||| S:430 E:433 ||| PRP
has  ||| S:433 E:437 ||| VBZ
been  ||| S:437 E:442 ||| VBN
shown  ||| S:442 E:448 ||| VBN
to  ||| S:448 E:451 ||| TO
be  ||| S:451 E:454 ||| VB
less  ||| S:454 E:459 ||| JJR
efficacious  ||| S:459 E:471 ||| NN
for  ||| S:471 E:475 ||| IN
large-vessel  ||| S:475 E:488 ||| JJ
occlusions ||| S:488 E:498 ||| NN
.  ||| S:498 E:500 ||| .
Mechanical  ||| S:500 E:511 ||| JJ
clot  ||| S:511 E:516 ||| JJ
extraction  ||| S:516 E:527 ||| NN
provides  ||| S:527 E:536 ||| VBZ
a  ||| S:536 E:538 ||| DT
therapeutic  ||| S:538 E:550 ||| JJ
option  ||| S:550 E:557 ||| NN
for  ||| S:557 E:561 ||| IN
those  ||| S:561 E:567 ||| DT
who  ||| S:567 E:571 ||| WP
are  ||| S:571 E:575 ||| VBP
ineligible  ||| S:575 E:586 ||| VBN
for ||| S:586 E:589 ||| IN
,  ||| S:589 E:591 ||| ,
or  ||| S:591 E:594 ||| CC
who  ||| S:594 E:598 ||| WP
do  ||| S:598 E:601 ||| VBP
not  ||| S:601 E:605 ||| RB
respond  ||| S:605 E:613 ||| VB
to ||| S:613 E:615 ||| TO
,  ||| S:615 E:617 ||| ,
conventional  ||| S:617 E:630 ||| JJ
ischemic  ||| S:630 E:639 ||| JJ
stroke  ||| S:639 E:646 ||| NN
treatment ||| S:646 E:655 ||| NN
.  ||| S:655 E:657 ||| .
We  ||| S:657 E:660 ||| PRP
reviewed  ||| S:660 E:669 ||| VBD
the  ||| S:669 E:673 ||| DT
initial  ||| S:673 E:681 ||| JJ
studies  ||| S:681 E:689 ||| NNS
of  ||| S:689 E:692 ||| IN
the  ||| S:692 E:696 ||| DT
Merci  ||| S:696 E:702 ||| NNP
Retriever  ||| S:702 E:712 ||| NNP
and  ||| S:712 E:716 ||| CC
Penumbra  ||| S:716 E:725 ||| NNP
System  ||| S:725 E:732 ||| NNP
for  ||| S:732 E:736 ||| IN
mechanical  ||| S:736 E:747 ||| JJ
clot  ||| S:747 E:752 ||| JJ
extraction ||| S:752 E:762 ||| NN
.  ||| S:762 E:764 ||| .
Baseline  ||| S:764 E:773 ||| JJ
patient  ||| S:773 E:781 ||| NN
characteristics ||| S:781 E:796 ||| NNS
,  ||| S:796 E:798 ||| ,
as  ||| S:798 E:801 ||| RB
well  ||| S:801 E:806 ||| RB
as  ||| S:806 E:809 ||| IN
revascularization  ||| S:809 E:827 ||| JJ
rates  ||| S:827 E:833 ||| NNS
and  ||| S:833 E:837 ||| CC
clinical  ||| S:837 E:846 ||| JJ
outcome ||| S:846 E:853 ||| NN
,  ||| S:853 E:855 ||| ,
were  ||| S:855 E:860 ||| VBD
examined ||| S:860 E:868 ||| VBN
.  ||| S:868 E:870 ||| .
Baseline  ||| S:870 E:879 ||| NNP
National  ||| S:879 E:888 ||| NNP
Institutes  ||| S:888 E:899 ||| NNPS
of  ||| S:899 E:902 ||| IN
Health  ||| S:902 E:909 ||| NNP
Stroke  ||| S:909 E:916 ||| NNP
Scale  ||| S:916 E:922 ||| NNP
scores  ||| S:922 E:929 ||| NNS
were  ||| S:929 E:934 ||| VBD
greater  ||| S:934 E:942 ||| JJR
than  ||| S:942 E:947 ||| IN
those  ||| S:947 E:953 ||| DT
observed  ||| S:953 E:962 ||| NN
in  ||| S:962 E:965 ||| IN
previous  ||| S:965 E:974 ||| JJ
IV  ||| S:974 E:977 ||| NNP
tPA  ||| S:977 E:981 ||| JJ
studies ||| S:981 E:988 ||| NNS
,  ||| S:988 E:990 ||| ,
consistent  ||| S:990 E:1001 ||| JJ
with  ||| S:1001 E:1006 ||| IN
large-vessel  ||| S:1006 E:1019 ||| JJ
occlusion ||| S:1019 E:1028 ||| NN
.  ||| S:1028 E:1030 ||| .
Successful  ||| S:1030 E:1041 ||| JJ
recanalization  ||| S:1041 E:1056 ||| NN
occurred  ||| S:1056 E:1065 ||| VBD
more  ||| S:1065 E:1070 ||| RBR
frequently  ||| S:1070 E:1081 ||| RB
than  ||| S:1081 E:1086 ||| IN
with  ||| S:1086 E:1091 ||| IN
IV  ||| S:1091 E:1094 ||| NNP
tPA  ||| S:1094 E:1098 ||| NNP
and  ||| S:1098 E:1102 ||| CC
was  ||| S:1102 E:1106 ||| VBD
associated  ||| S:1106 E:1117 ||| VBN
with  ||| S:1117 E:1122 ||| IN
improved  ||| S:1122 E:1131 ||| JJ
clinical  ||| S:1131 E:1140 ||| JJ
outcome  ||| S:1140 E:1148 ||| NN
and  ||| S:1148 E:1152 ||| CC
mortality ||| S:1152 E:1161 ||| NN
.  ||| S:1161 E:1163 ||| .
Symptomatic  ||| S:1163 E:1175 ||| JJ
intracranial  ||| S:1175 E:1188 ||| JJ
hemorrhage  ||| S:1188 E:1199 ||| NN
and  ||| S:1199 E:1203 ||| CC
mortality  ||| S:1203 E:1213 ||| NN
rates  ||| S:1213 E:1219 ||| NNS
were  ||| S:1219 E:1224 ||| VBD
greater  ||| S:1224 E:1232 ||| JJR
than  ||| S:1232 E:1237 ||| IN
those  ||| S:1237 E:1243 ||| DT
seen  ||| S:1243 E:1248 ||| VBN
with  ||| S:1248 E:1253 ||| IN
IV  ||| S:1253 E:1256 ||| NNP
tPA ||| S:1256 E:1259 ||| NNP
.  ||| S:1259 E:1261 ||| .
Mechanical  ||| S:1261 E:1272 ||| JJ
clot  ||| S:1272 E:1277 ||| JJ
extraction  ||| S:1277 E:1288 ||| NN
can  ||| S:1288 E:1292 ||| MD
be  ||| S:1292 E:1295 ||| VB
performed  ||| S:1295 E:1305 ||| VBN
safely  ||| S:1305 E:1312 ||| RB
in  ||| S:1312 E:1315 ||| IN
patients  ||| S:1315 E:1324 ||| NNS
with  ||| S:1324 E:1329 ||| IN
large-vessel  ||| S:1329 E:1342 ||| JJ
occlusions ||| S:1342 E:1352 ||| NN
,  ||| S:1352 E:1354 ||| ,
and  ||| S:1354 E:1358 ||| CC
successful  ||| S:1358 E:1369 ||| JJ
recanalization  ||| S:1369 E:1384 ||| NN
resulted  ||| S:1384 E:1393 ||| VBD
in  ||| S:1393 E:1396 ||| IN
better  ||| S:1396 E:1403 ||| JJR
clinical  ||| S:1403 E:1412 ||| JJ
outcomes  ||| S:1412 E:1421 ||| NNS
than  ||| S:1421 E:1426 ||| IN
those  ||| S:1426 E:1432 ||| DT
without ||| S:1432 E:1439 ||| NN
.  ||| S:1439 E:1441 ||| .
Mechanical  ||| S:1441 E:1452 ||| JJ
thrombectomy  ||| S:1452 E:1465 ||| NN
provides  ||| S:1465 E:1474 ||| VBZ
a  ||| S:1474 E:1476 ||| DT
therapeutic  ||| S:1476 E:1488 ||| JJ
option  ||| S:1488 E:1495 ||| NN
for  ||| S:1495 E:1499 ||| IN
ischemic  ||| S:1499 E:1508 ||| JJ
stroke  ||| S:1508 E:1515 ||| NN
patients  ||| S:1515 E:1524 ||| NNS
who  ||| S:1524 E:1528 ||| WP
are  ||| S:1528 E:1532 ||| VBP
ineligible  ||| S:1532 E:1543 ||| VBN
for ||| S:1543 E:1546 ||| IN
,  ||| S:1546 E:1548 ||| ,
or  ||| S:1548 E:1551 ||| CC
who  ||| S:1551 E:1555 ||| WP
do  ||| S:1555 E:1558 ||| VBP
not  ||| S:1558 E:1562 ||| RB
respond  ||| S:1562 E:1570 ||| VB
to ||| S:1570 E:1572 ||| TO
,  ||| S:1572 E:1574 ||| ,
IV  ||| S:1574 E:1577 ||| NNP
thrombolytics ||| S:1577 E:1590 ||| NN
.  ||| S:1590 E:1592 ||| .
Further  ||| S:1592 E:1600 ||| JJ
studies ||| S:1600 E:1607 ||| NNS
,  ||| S:1607 E:1609 ||| ,
including  ||| S:1609 E:1619 ||| VBG
randomized  ||| S:1619 E:1630 ||| JJ
clinical  ||| S:1630 E:1639 ||| JJ
trials ||| S:1639 E:1645 ||| NNS
,  ||| S:1645 E:1647 ||| ,
are  ||| S:1647 E:1651 ||| VBP
needed  ||| S:1651 E:1658 ||| VBN
to  ||| S:1658 E:1661 ||| TO
validate  ||| S:1661 E:1670 ||| VB
these  ||| S:1670 E:1676 ||| DT
findings ||| S:1676 E:1684 ||| NNS
.  ||| S:1684 E:1686 ||| .
